Morphing VC into the Buyout Game
Executive Summary
Venture capitalists are avoiding health care, in part because they make more money elsewhere, in part because their funds are too large for many of the start-ups looking for capital. One alternative: buyouts, on the model of Warburg's acquisition of American Medical Systems.
You may also be interested in...
Takeda Culls Shunned Ex-Shire Asset After EC Lifts Antimonopoly Concerns
Japanese firm says it will end SHP647 development after trying unsuccessfully to find takers for GI drug similar to its blockbuster Entyvio, first flagged by European authorities over competition worries.
J&J’s Baby Powder Announcement Renews NGO Calls For Industry, FDA To End Use Of Talc In Cosmetics
The Environmental Working Group and US PIRG suggest that beauty and personal-care firms should avoid using talc in loose powders, if not all cosmetic products, and that the US FDA should consider banning the ingredient due to the potential for asbestos contamination, among other concerns.
Seattle Biologics Firm Offers COVID-19 ‘Vaccine’ OTC Before Warnings By State, Federal Agencies
When businesses rapidly pivot to offering consumer health products and services, they’re likely not contemplating compliance with FDA regulations. Recent warning letters are more proof COVID-19 represents opportunities for numerous businesses that aren’t prepared to follow or simply aren’t aware of FDA regulations.
Need a specific report? 1000+ reports available
Buy Reports